Search clinical trials for: 13-valent Pnumococcal Conjugate vaccine

Total 953 results

National and Kapodistrian University of Athens

Unknown

Study of 7-valent Pneumococcal Conjugate Vaccine in Children With Idiopathic Nephrotic Syndrome

Idiopathic Nephrotic Syndrome

Greece
Sinovac Research and Development Co., Ltd.

Completed

Immunogenicity and Safety of an Inactivated COVID-19 Vaccine

COVID-19

China
Pfizer

Completed

Immunogenicity and Safety Study of 1 and 2 Doses of GlaxoSmithKline (GSK) Biologicals' Meningococcal Vaccine MenACWY-TT (GSK134612) in Toddlers, Persistence up to 5 Years After Vaccination and Co-administration With Pfizer's Prevenar 13™Vaccine

Infections, Meningococcal

Australia, Canada, Czechia, Panama, South Africa, Turkey
Merck Sharp & Dohme LLC

Recruiting

A Clinical Study of the V116 Vaccine for Children and Teenagers (V116-013) (STRIDE-13)

Pneumococcal Infection

France, United States, Japan, Canada, Turkey, Finland, Spain, Poland, Sweden, Chile, Colombia, Israel, Thailand
Sanofi Pasteur, a Sanofi Company

Completed

Safety of a Quadrivalent Meningococcal Conjugate Vaccine Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers (MET41)

Healthy Volunteers (Meningococcal Infection)

Puerto Rico, United States
GlaxoSmithKline

Active, not recruiting

Study to Assess the Immune Response, the Safety and the Reactogenicity of Respiratory Syncytial Virus (RSV) Prefusion Protein 3 Older Adult (OA) (RSVPreF3 OA) Investigational Vaccine When co Administered With PCV20 in Older Adults

Respiratory Syncytial Virus Infections

Spain, United States, Belgium, Poland
Sidney Kimmel Comprehensive Cancer Center at Johns...
National Cancer Institute (NCI)

Terminated

Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide

Transplant-Related Cancer

United States
PATH

Completed

Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers

Pneumonia, Pneumococcal

Kenya
Cedars-Sinai Medical Center

Completed

Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease

Crohn Disease | Ulcerative Colitis | Inflammatory Bowel Disease

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-experienced Adults (V116-006, STRIDE-6)

Pneumonia, Pneumococcal

United States, Canada, France, Israel, Italy, Japan, Korea, Republic of, Spain, Taiwan
University of British Columbia
Canadian Institutes of Health Research (CIHR); University of Calgary; Alberta... and other collaborators

Completed

CIRN Pneumococcal Conjugate Vaccine 1 vs. 2 Dose Priming Study

Streptococcus Pneumoniae Infection | Invasive Pneumococcal Disease, Protection Against

Canada
PT Bio Farma

Completed

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)

Safety Issues

Indonesia
Lakehead University

Completed

The Effect of Previous Pneumococcal Immunization on the Immune Response of Patients With Severe CKD to Prevnar 13

Chronic Kidney Diseases

Canada
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011)

Pneumococcal Infection
University of Toledo Health Science Campus
National Institutes of Health (NIH)

Completed

Immune Response to Pneumococcal Vaccination in HIV Infected Individuals

Pneumococcal Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

9-valent CRM 197 Pneumococcal

Pneumococcal Infection

United States
GlaxoSmithKline

Completed

Booster and Catch-up Vaccination With Vaccine GSK1024850A

Infections, Streptococcal

India
GlaxoSmithKline

Completed

Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines

Infections, Rotavirus

Czech Republic
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of V116 in Adults Living With Human Immunodeficiency Virus (HIV) (V116-007, STRIDE-7)

Pneumococcal Disease

United States, Belgium, Chile, France, South Africa, Thailand
Sanofi Pasteur, a Sanofi Company

Completed

Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adults, Adolescents, Children, and Toddlers in India and Healthy Adolescents and Children in the Republic of South Africa (MET55)

Healthy Volunteers (Meningococcal Infection)

India, South Africa
The Hospital for Sick Children

Completed

Does the Order in Which Vaccines Are Administered Affect Pain Response?

Pain

Canada
Cambridge University Hospitals NHS Foundation Trust
Arthritis Research UK

Unknown

Acquired Immunodeficiency in ANCA Associated Vasculitis (ACQUIVAS)

Systemic Vasculitis
Pfizer

Completed

Prevenar Special Use-result Surveillance in Japan (Regulatory PostMarketing Commitment Plan)

Streptococcus Pneumoniae | Pneumococcal Vaccine

Japan
Naval Health Research Center
U.S. Army Medical Research and Development Command

Completed

Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits

Pneumonia | Acute Respiratory Disease

United States
Affinivax, Inc.

Completed

A Study to Assess the Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator

Healthy Volunteers | Pneumococcal Disease

United States
Sanofi

Completed

Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers

Pneumococcal Infections | Pneumococcal Pneumonia

Switzerland
Merck Sharp & Dohme LLC

Completed

V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019)

Measles | Rubella | Mumps | Varicella
Eli Lilly and Company

Terminated

A Study of LY3127804 in Participants With COVID-19

COVID-19 | Pneumonia

United States
GlaxoSmithKline

Completed

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age

Infections, Rotavirus

Taiwan
GlaxoSmithKline

Completed

A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants

Infections, Streptococcal

Bangladesh
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life

Measles | Rubella | Mumps | Measles-Mumps-Rubella Vaccine

Finland, Thailand, United States, Spain, Czechia, Puerto Rico, Malaysia
Sanofi Pasteur, a Sanofi Company

Completed

Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults

Pneumococcal Infections | Streptococcus Pneumoniae Infections | Pneumococcal Pneumonia

Switzerland
GlaxoSmithKline
Affinivax, Inc.

Recruiting

A Phase 2 Study to Evaluate the Safety, Tolerability, and Immunogenicity of AFX3772 Vaccine in Healthy Infants

Pneumococcal Infections | Pneumonia, Pneumococcal | Pneumonia, Bacterial

United States, Puerto Rico
University Hospital Tuebingen

Completed

Effect of Morning vs. Evening Vaccination on Hypoxia and Bradycardia of Preterm Infants: a Randomised Controled Trial

Premature Birth | Intermittent Hypoxiema

Germany
Karolinska University Hospital

Completed

Pneumococcal Vaccine in Untreated CLL Patients

Chronic Lymphocytic Leukemia

Sweden
National Institute on Aging (NIA)

Completed

PPV: Pneumococcal Polysaccharide Vaccine in Older Adults

Aging

United States
UMC Utrecht
Netherlands Organisation for Scientific Research

Completed

Prevention of Respiratory Infections and MAnagement Among Children (PRIMAKid)

Recurrent Upper and Lower Respiratory Tract Infections (RTIs)

Netherlands
Public Health England

Completed

Evaluation of the Immunogenicity and Reactogenicity of a Pneumococcal Conjugate Vaccine in Healthy Adults

Streptococcus Pneumoniae
Pfizer

Completed

A Trial Evaluating a 7-valent Pneumococcal Conjugate Vaccine Given With Diphtheria, Tetanus, and Acellular Pertussis Vaccine (DTaP) in Healthy Japanese Infants.

Healthy Subjects

Japan
Papua New Guinea Institute of Medical Research
The University of Western Australia

Unknown

Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children (PCV1103)

Pneumonia | Sepsis | Meningitis | Otitis Media | Bacteraemia

Papua New Guinea
University Hospital Southampton NHS Foundation...
Solent NHS Trust

Unknown

Paediatric Post Pneumococcal Conjugate Vaccine Nasopharyngeal Carriage Study

Pneumococcal Conjugate Vaccine | S. Pneumoniae

United Kingdom
Pfizer

Completed

Study Assessing the Effect of Medications to Prevent Fever on Prevenar 13®

Pneumococcal Vaccines

Poland
GlaxoSmithKline

Completed

Safety & Immunogenicity Study of 10-Valent Pneumococcal Conjugate Vaccine When Administered as a 2-Dose Schedule

Infections, Streptococcal

Slovakia, Sweden, Denmark, Norway
Centre Hospitalier Universitaire de Saint Etienne
Pfizer

Terminated

Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBD (PneumoMICI)

Bowel Diseases, Inflammatory | Infections, Pneumococcal

France
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Children With Sickle Cell Disease (V114-023/PNEU-SICKLE)

Pneumococcal Infections

United States, Brazil, Colombia, Dominican Republic, Greece, Italy, Panama
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE) (PNEU-AGE)

Pneumococcal Infections

Taiwan, United States, Canada, Japan, Spain
Merck Sharp & Dohme LLC

Completed

Lot-to-Lot Consistency of V114 in Healthy Adults (V114-020) (PNEU-TRUE)

Pneumococcal Infections | Pneumonia, Pneumococcal

United States, Australia, Chile, Denmark, Finland, United Kingdom
Nuron Biotech Inc.

Unknown

A Phase 2, Multicenter, Open-label Study to Assess the Immunogenicity of an Investigational Hib Vaccine (NU300)in Toddlers

Infectious Disease

United States
GlaxoSmithKline

Completed

Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A

Streptococcus Pneumoniae | Infections, Streptococcal

Finland
Public Health England
Institute of Child Health; National Institute of Biological Standards and Control

Completed

Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of Life (Sched2)

Pneumococcal Infections | Meningococcal Infections

United Kingdom

3

Subscribe